{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:38:58Z","timestamp":1761237538649},"reference-count":22,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.vaccine.2008.04.033","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T18:31:32Z","timestamp":1210098692000},"page":"3438-3442","source":"Crossref","is-referenced-by-count":11,"title":["Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults"],"prefix":"10.1016","volume":"26","author":[{"given":"A.H.","family":"Roukens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Vossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"van Dissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.04.033_bib1","series-title":"Vaccines","first-page":"743","article-title":"Rabies Vaccine","author":"Plotkin","year":"1999"},{"key":"10.1016\/j.vaccine.2008.04.033_bib2","first-page":"425","article-title":"Weekly epidemiological record","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Rabies Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2008.04.033_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S0022172400070583","article-title":"Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization","volume":"89","author":"Turner","year":"1982","journal-title":"J Hyg (Lond)"},{"issue":"8345","key":"10.1016\/j.vaccine.2008.04.033_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(83)90288-X","article-title":"An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis","volume":"2","author":"Warrell","year":"1983","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2008.04.033_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/hv.2.5.3197","article-title":"Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1mL","volume":"2","author":"Madhusudana","year":"2006","journal-title":"Hum Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.04.033_bib6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.04.033_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0264-410X(87)90102-2","article-title":"Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man","volume":"5","author":"Nicholson","year":"1987","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.04.033_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0264-410X(89)90152-7","article-title":"Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization","volume":"7","author":"Dreesen","year":"1989","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.04.033_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(92)90029-J","article-title":"Longevity of rabies antibody titer in recipients of human diploid cell rabies vaccine","volume":"10","author":"Briggs","year":"1992","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.04.033_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1708-8305.2006.00097.x","article-title":"Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine","volume":"14","author":"Malerzcyk","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2008.04.033_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(75)91761-4","article-title":"Immunogenicity and acceptability of a human diploid cell culture rabies vaccine in volunteers","volume":"1","author":"Aoki","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.033_bib12","unstructured":"Recommendations of the Advisory Committee on Immunization Practices (ACIP). Human rabies prevention \u2013 United States, 1999;48(RR-1):1\u201321."},{"key":"10.1016\/j.vaccine.2008.04.033_bib13","unstructured":"World Health Organization Department of Communicable Diseases Surveillance and Responses. Current WHO guide for rabies pre- and post-exposure treatment in humans. http:\/\/www.who.int\/rabies\/en\/WHO_guide_rabies_pre_post_exp_ treat_humans.pdf (accessed on 24-08-2007)."},{"key":"10.1016\/j.vaccine.2008.04.033_bib14","unstructured":"Landelijk Co\u00f6rdinatiecentrum Reizigersadvisering (LCR). Dutch national guidelines for traveler's vaccinations and advices; 2007."},{"key":"10.1016\/j.vaccine.2008.04.033_bib15","unstructured":"Center for Disease Control, Mantoux Tuberculosis Skin Test Facilitator Guide. http:\/\/www.cdc.gov\/tb\/pubs\/Mantoux\/part1.htm (accessed 3rd of September 2007)."},{"issue":"1","key":"10.1016\/j.vaccine.2008.04.033_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.04.033_bib17","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","article-title":"Multicenter comparative study of a new ELISA, PLATELIATM RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.04.033_bib18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/515267","article-title":"Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy","volume":"177","author":"Strady","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.04.033_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"issue":"22","key":"10.1016\/j.vaccine.2008.04.033_bib20","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","article-title":"Serum antibody response after intradermal vaccination against influenza","volume":"351","author":"Belshe","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2008.04.033_bib21","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with intradermal injection of influenza vaccine","volume":"351","author":"Kenney","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.04.033_bib22","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: A randomized controlled non-inferiority trial","volume":"3","author":"Roukens","year":"2008","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08004866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08004866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T05:27:41Z","timestamp":1684387661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08004866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":22,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0264410X08004866"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}